CABA
Cabaletta Bio, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-23
Figures on this page computed 2026-11-08 12:56 UTC
Last close
1.30USD
Market data, 2026-11-06
Weekly closes, 2025-11-07 to 2026-11-06
Over that span: -49.0%
Except where said otherwise: 10-K for 2025, filed 2026-03-23
n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001759138-26-000011
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-03-23
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001759138-26-000011
- Reported in
- USD
- 10-K for 2025, filed 2026-03-23
- 10-K for 2025, filed 2026-03-23
- 10-K for 2025, filed 2026-03-23
- 10-Q for 2025, filed 2026-08-13
- 10-K for 2025, filed 2026-03-23
- 10-Q for 2025, filed 2026-08-13
n/aNet margin
We do not hold this figure for this company, so there is nothing to place.
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001759138-26-000011
- Reported in
- USD
- 10-K for 2025, filed 2026-03-23
- 10-K for 2025, filed 2026-03-23
n/aFCF margin
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001759138-26-000011
- Reported in
- USD
- 10-K for 2025, filed 2026-03-23
- 10-K for 2025, filed 2026-03-23
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001759138-26-000011
- Reported in
- USD
- 10-K for 2025, filed 2026-03-23
- 10-Q for 2025, filed 2026-08-13
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Growth is the furthest below its sector's middle: 0.26 against 0.46 on the market's range.
- Growth-44.9%26 of 100, below its sector
- Returns on capital-149.8%7 of 100, below its sector
- Marginsn/anot placed
- Price2.0x46 of 100, above its sector
- Safety2.7767 of 100, below its sector
- What it pays outn/anot placed
- Margins: n/aWe do not hold this figure for this company, so there is nothing to place.
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Five bars, one line
lens 7 of 9Each against its own average
3 of 5 readExcept where said otherwise: 10-K for 2025, filed 2026-03-23
- Salesn/a
Its own average over 0 years.
- Profit2.94x
Its own average over 9 years, -57.0M.
- Free cash flow2.29x
Its own average over 7 years, -57.9M.
- Debtn/a
Its own average over 0 years.
- Price0.17x
Its own average over 8 years, 8. Market data, 2026-11-06
Profit is furthest from its own average, at 2.94 times.
The filed years, as a table
3Each line is 100 at 2017-12-31, the first year we hold.
| Filed year | Shares in issue |
|---|---|
| 2017-12-31 | 100.0 |
| 2022-12-31 | 24.7 |
| 2023-12-31 | 4.9 |
How shares in issue was got
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001759138-26-000011
- Reported in
- USD
Figures behind the shape
Growth
-44.9%faster is higher, placed against 4,950 companies as of 2026-11-07
Five-year revenue growth raten/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
One-year change in net income-44.9%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Returns on capital
-149.8%higher is higher, placed against 5,089 companies as of 2026-11-07
Return on invested capitaln/a
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001759138-26-000011
- Reported in
- USD
- 10-K for 2025, filed 2026-03-23
- 10-K for 2025, filed 2026-03-23
- 10-K for 2025, filed 2026-03-23
- 10-Q for 2025, filed 2026-08-13
- 10-K for 2025, filed 2026-03-23
- 10-Q for 2025, filed 2026-08-13
Return on equity-149.8%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001759138-26-000011
- Reported in
- USD
- 10-K for 2025, filed 2026-03-23
- 10-Q for 2025, filed 2026-08-13
Return on assets-101.7%
Net Income / Total Assets x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001759138-26-000011
- Reported in
- USD
- 10-K for 2025, filed 2026-03-23
- 10-Q for 2025, filed 2026-08-13
Margins
n/aWe do not hold this figure for this company, so there is nothing to place.
wider is higher, with no cohort held
Gross marginn/a
We do not hold this figure for this company, so there is nothing to place.
Gross Profit / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001759138-26-000011
- Reported in
- USD
- 10-K for 2025, filed 2026-03-23
- 10-K for 2025, filed 2026-03-23
Operating marginn/a
We do not hold this figure for this company, so there is nothing to place.
Operating Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001759138-26-000011
- Reported in
- USD
- 10-K for 2025, filed 2026-03-23
- 10-K for 2025, filed 2026-03-23
Net marginn/a
We do not hold this figure for this company, so there is nothing to place.
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001759138-26-000011
- Reported in
- USD
- 10-K for 2025, filed 2026-03-23
- 10-K for 2025, filed 2026-03-23
Free cash flow marginn/a
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001759138-26-000011
- Reported in
- USD
- 10-K for 2025, filed 2026-03-23
- 10-K for 2025, filed 2026-03-23
Price
2.0xcheaper is higher, placed against 4,482 companies as of 2026-11-07
Price to earningsn/a
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001759138-26-000011
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-03-23
Price to book2.0x10-Q for 2025, filed 2026-08-13
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001759138-26-000039
- Reported in
- USD
- computed
- 10-Q for 2025, filed 2026-08-13
EV to EBITDAn/a
We do not hold this figure for this company, so there is nothing to place.
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001759138-26-000011
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-03-23
- 10-K for 2025, filed 2026-03-23
- 10-Q for 2025, filed 2026-08-13
- 10-K for 2025, filed 2026-03-23
Price to sales ration/a
We do not hold this figure for this company, so there is nothing to place.
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001759138-26-000011
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-03-23
- 10-K for 2025, filed 2026-03-23
Safety
2.77safer is higher, placed against 4,231 companies as of 2026-11-07
Debt to equityn/a
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001759138-26-000011
- Reported in
- USD
- 10-K for 2025, filed 2026-03-23
- 10-Q for 2025, filed 2026-08-13
Current ratio2.7710-Q for 2025, filed 2026-08-13
Current Assets / Current Liabilities
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001759138-26-000039
- Reported in
- USD
- 10-Q for 2025, filed 2026-08-13
- 10-Q for 2025, filed 2026-08-13
Interest coveragen/a
We do not hold this figure for this company, so there is nothing to place.
Operating Income / Interest Expense
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001759138-26-000011
- Reported in
- USD
- 10-K for 2025, filed 2026-03-23
- 10-K for 2025, filed 2026-03-23
Altman Z-Scoren/a
We do not hold this figure for this company, so there is nothing to place.
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- Computed from the 10-K for 2025, filed 2026-03-23
- Computed from the 10-K for 2025, filed 2026-03-23
- Computed from the 10-K for 2025, filed 2026-03-23
- Computed from the 10-K for 2025, filed 2026-03-23
- Computed from the 10-K for 2025, filed 2026-03-23
What it pays out
n/aWe do not hold this figure for this company, so there is nothing to place.
more, and better covered, is higher, with no cohort held
Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001759138-26-000011
- Reported in
- USD
- 10-K for 2025, filed 2026-03-23
- Computed from the 10-K for 2025, filed 2026-03-23
- 10-K for 2025, filed 2026-03-23
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.